• USC to Use Generative AI to Make Cancer Clinical Trials More Efficient

    Feb 20 | Clinical Research News | The Norris Comprehensive Cancer Center, owned and operated by the University of Southern California (USC) through its Keck School of Medicine, will serve as the initial testing ground for a platform powered by generative artificial intelligence (AI) that is designed to streamline clinical trial operations. This is the first U.S.-based academic site in the research network of California startup company Ryght. More

  • Fraud and Misconduct in Clinical Trials Not a Trivial Matter

    Feb 18 | Clinical Research News | In a debate at the recent Summit for Clinical Ops Executives (SCOPE) over whether fraud and misconduct in clinical trials represent a marginal nuisance or a major problem, the argument for it being a serious situation easily won the day based on a show of hands in the room. Making the case for an embarrassment of breaches was Jonathan Rowe, head of R&D quality, operations and risk management at management consulting and technology firm ZS. More

  • Why the Human Touch is Still Present in the Technological Era

    Feb 14 | Clinical Research News | The healthcare industry has experienced tremendous growth in the use of artificial intelligence (AI) and large language models (LLMs) over the past decade, both of which are already impacting how precision medicine is applied. AI plays a key role in identifying patterns within complex datasets, improving accuracy, and facilitating the exploration of vast volumes of clinical and ‘omics-based research data. More

  • Crosstree Capital Partners’ Shane Senior Discusses AI’s Disruption of Clinical Trials

    Feb 12 | Clinical Research News | At the Venture, Innovation and Partnering forum at last week’s SCOPE Summit in Orlando, Shane Senior, the Managing Director and Owner of Crosstree Capital Partners, delivered a bit of an ultimatum: evolve or die! While the decentralized trial revolution never quite materialized, the AI revolution underway in clinical trials is poised for more dramatic change than ever in the next five years. More

  • Walgreens Clinical Trials Puts Focus on Patient ‘Readiness’ for Recruitment

    Feb 11 | Clinical Research News | Incorporating the lived experience of patients into strategic planning around clinical trials, and outreach to historically under-represented communities, are central features of the operational model of Walgreens Clinical Trials. The key is to foster a sense of trust and long-term connection with different population groups—not show up suddenly and unexpectedly with a flashy recruitment campaign that is destined to “fall flat.” More

  • Anju, Biorce, Medidata, Phastar Take Home Best of Show Awards from SCOPE 2025

    Feb 06 | Clinical Research News | Winners were named in the 2025 SCOPE Best of Show Awards yesterday. With more than 60 new product finalists on display on the Exhibit Hall floor and more than 300 attendees voting on their favorite new products, the Best of Show program at SCOPE highlights the very best in innovation and new technologies in clinical research. More

  • Narrowing the Gap Between Clinical Research and Clinical Care

    Feb 05 | Clinical Research News | The growing convergence between clinical research and clinical care—and ways the second Trump administration will be encouraging and supporting movement in that direction—was the topic of the opening keynote presentation made at this week’s Summit for Clinical Ops Executives (SCOPE) in Orlando. More

  • Grove AI Named the 2025 Participant Engagement Award Winner

    Feb 04 | Clinical Research News | In a contest focused on the finalist themes of AI (artificial intelligence), DEI (diversity, equity and inclusion), and community engagement, a winner was chosen to be the 9th Annual Participant Engagement Award during opening ceremonies yesterday at the Summit for Clinical Ops Executives in Orlando. This year’s top honor went to Grove AI for personalizing participant recruitment and engagement at scale using a smart bot named Grace acting as a clinical research assistant. More

  • Best of Show Finalists at SCOPE 2025

    Jan 31 | Clinical Research News | The Best of Show People’s Choice Award Finalists are now announced for next week’s 2025 Summit for Clinical Ops Executives (SCOPE). With a record number of finalists, this promises to be the most competitive year yet for clinical new products. More

  • Proceed With Caution When Decentralizing Oncology Trials

    Jan 30 | Clinical Research News | Patients with cancer typically have a strong emotional connection with their doctors and nurses that is an important part of their healing process. It follows that those taking an investigational therapy should be offered decentralized clinical trial (DCT) components that serve to enhance that bond rather than do away with it, according to Peter O’Neill, vice president of clinical operations at TuHURA Biosciences, Inc. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More